{
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "leverage": true,
    "inverse": false,
    "derivatives": true,
    "swaps": true,
    "complex_factors": [
        "3x daily leverage",
        "Synthetic replication using swaps",
        "Leveraged exposure to futures contracts",
        "Daily compounding effect",
        "High risk profile (7/7)",
        "Counterparty risk from swap agreements",
        "Complex index tracking (futures rolling mechanism)"
    ],
    "classification": "complex",
    "supporting_data": "The product is classified as complex under MiFID II due to multiple factors: 1) It uses synthetic replication via swap agreements to achieve 3x daily leveraged exposure to gilts futures, 2) The daily compounding effect creates a non-linear relationship to the underlying index, 3) The high risk rating (7/7) and warnings about potential total loss indicate significant complexity, 4) The product requires understanding of futures rolling mechanisms and leverage effects, 5) The PRIIPs document explicitly states it's not suitable for retail investors without specific knowledge, 6) The collateralized swap structure introduces counterparty risk that may be difficult for retail investors to assess. While the product is fully collateralized, the combination of leverage, derivatives, and complex index tracking mechanisms makes it unsuitable for typical retail investors under MiFID II standards.",
    "confidence": 95
}